Adele M. Gulfo

update update


Bemis creates exceptional packaging for food, consumer product, healthcare, and industrial applications.

Bemis has successfully completed its merger with Amcor, and the combined company is now traded on the NYSE under AMCR. Please visit our investor site at

For reference, this site contains historical information only for Bemis.

3 Image Hover Swap - Economic, Environmental, Social

Adele M. Gulfo

Chief of Commercial Development, Roivant Sciences, Inc.

Adele M. Gulfo is Chief of Commercial Development at Roivant Sciences, Inc. Prior to her current role, Adele served as EVP & Head of Global Commercial Development and Chief Strategy Officer of Mylan N.V. (NASDAQ: MYL), a leading global pharmaceutical company, from 2014 to 2018. Prior to joining Mylan, Ms. Gulfo spent a total of 14 years at Pfizer, Inc. and legacy companies, most recently as President, Latin America, before that as President and General Manager, U.S. Primary Care, and earlier where she launched LIPITOR in 1997 to become the world's best-selling medicine. Previously, Ms. Gulfo held leadership positions at AstraZeneca Pharmaceuticals, SpectraTech Inc., and Fischer Scientific. She holds eight patents.

Ms. Gulfo's experience in the healthcare industry brings valuable marketing, operational and strategic insight to the Board. She has also held various leadership roles with global public companies, giving her valuable strategic experience and perspective in understanding global challenges and opportunities. 

Director since 2015

Bemis Board Committee:
Audit Committee